Back to Search
Start Over
Molecular and clinical pharmacology of psoriasis
Molecular and clinical pharmacology of psoriasis
- Source :
- Clinical Pharmacology & Therapeutics; Part 16/November 1974, Vol. 16 Issue: 5 p919-921, 3p
- Publication Year :
- 1974
-
Abstract
- Psoriasis appears in most cases to be a genetic disease8in which stratified squamous epithelium (epidermis) of skin in involved versus normalāappearing uninvolved areas has the following prototypic features: (1) excessive cell proliferation and an accelerated cell cycle of the proliferating cells21; (2) incomplete epidermal specialization (keratinization) for tissue function; and (3) marked increase in glycogen content.7It has been widely held that the relative lack of epidermal specialization is due to the rapid transit of cells through the epidermis (i.e., the cells are shed from the patient without sufficient time for normal keratinization to occur). However, an alternate explanation is that the excessive cell proliferation is the result of an inability of differentiated basal cells to make the commitment of specialization. For this reason we have listed incomplete specialization as one of the three characteristic findings in psoriasis lesions.
Details
- Language :
- English
- ISSN :
- 00099236 and 15326535
- Volume :
- 16
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Clinical Pharmacology & Therapeutics
- Publication Type :
- Periodical
- Accession number :
- ejs41228174
- Full Text :
- https://doi.org/10.1002/cpt1974165part2919